Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance-Reference-Cited by-同舟云学术

Adverse Disease Features in Gleason Score 3 + 4 “Favorable Intermediate-Risk” Prostate Cancer: Implications for Active Surveillance

Published:2017-09 Issue:3 Volume:72 Page:442-447
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Morlacco Alessandro,Cheville John C.,Rangel Laureano J.,Gearman Derek J.,Karnes R. Jeffrey

Publisher

Elsevier BV

Subject

Urology

Reference22 articles.

1. Long-term follow-up of a large active surveillance cohort of patients with prostate cancer;Klotz;J Clin Oncol,2015

2. Outcomes of active surveillance for men with intermediate-risk prostate cancer;Cooperberg;J Clin Oncol,2011

3. NCCN clinical practice guidelines in oncology (NCCN Guidelines®). Prostate cancer, version 3.2016. National Comprehensive Cancer Network Web site. https://www.nccn.org/store/login/login.aspx?ReturnURL=http://www.nccn.org/professionals/physician_gls/pdf/prostate.pdf.

4. A new risk classification system for therapeutic decision making with intermediate-risk prostate cancer patients undergoing dose-escalated external-beam radiation therapy;Zumsteg;Eur Urol,2013

5. Gleason upgrading with time in a large prostate cancer active surveillance cohort;Jain;J Urol,2015

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Automated Ki‐67 labeling index assessment in prostate cancer using artificial intelligence and multiplex fluorescence immunohistochemistry;The Journal of Pathology;2023-03-06

2. Clinical Significance of Perineural Invasion in Men With Grade Group 1 Prostate Cancer on Active Surveillance;Journal of Urology;2023-01

3. Risk and predictors of adverse pathology after radical prostatectomy in patients diagnosed with IUSP 1–2 prostate cancer at MRI-targeted biopsy: a multicenter analysis;World Journal of Urology;2022-12-19

4. Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression;European Urology Oncology;2022-12

5. Pathological Accuracy in Prostate Cancer: Single-Center Outcomes of 3 Different Magnetic Resonance Imaging-Targeted Biopsy Techniques and Random Systematic Biopsy;Türk Üroloji Dergisi/Turkish Journal of Urology;2022-10-03